Daiichi Sankyo Netherlands BV

DAIICHI SANKYO NETHERLANDS BV is the Dutch subsidiary of DAIICHI SANKYO Co.. Ltd., A leading international pharmaceutical company, created in 2005 by a merger of SANKYO Co.. Ltd. (Familiar from pravastatin for the treatment of hypercholesterolemia) and Daiichi Co.. Ltd. (Familiar from levofloxacin, an antibiotic from the group of fluoroquinolones).

From this merger is the second largest pharmaceutical company in Japan arise. With a worldwide turnover of approximately U.S. $ 6 billion DAIICHI SANKYO is one of the twenty largest pharmaceutical companies in the world. The "pipeline" of DAIICHI SANKYO is well filled, diverse and promising. DAIICHI SANKYO develop drugs that have the potential "first in class or best in class' to be.

DAIICHI SANKYO's international headquarters is located in Tokyo, Japan, and Europe in Munich, Germany. Except in Japan and Europe DAIICHI SANKYO a branch in USA
Type: NORMAL
Address: Wilgenlaan 5 Wilgenlaan 5, 1161 JK, Zwanenburg
Website: http://www.daiichi-sankyo.nl
Phone: +31 (0) 20 407 2072
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.